254 related articles for article (PubMed ID: 22507773)
1. Thalassemia.
Aydinok Y
Hematology; 2012 Apr; 17 Suppl 1():S28-31. PubMed ID: 22507773
[TBL] [Abstract][Full Text] [Related]
2. Transfusional iron overload and iron chelation therapy in thalassemia major and sickle cell disease.
Marsella M; Borgna-Pignatti C
Hematol Oncol Clin North Am; 2014 Aug; 28(4):703-27, vi. PubMed ID: 25064709
[TBL] [Abstract][Full Text] [Related]
3. Common queries in thalassemia care.
Panigrahi I; Marwaha RK
Indian Pediatr; 2006 Jun; 43(6):513-8. PubMed ID: 16820660
[TBL] [Abstract][Full Text] [Related]
4. Management of the aging beta-thalassemia transfusion-dependent population - The Italian experience.
Pinto VM; Poggi M; Russo R; Giusti A; Forni GL
Blood Rev; 2019 Nov; 38():100594. PubMed ID: 31416718
[TBL] [Abstract][Full Text] [Related]
5. Beta-thalassemia.
Rund D; Rachmilewitz E
N Engl J Med; 2005 Sep; 353(11):1135-46. PubMed ID: 16162884
[No Abstract] [Full Text] [Related]
6. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
[TBL] [Abstract][Full Text] [Related]
7. Challenges in chronic transfusion for patients with thalassemia.
Lal A
Hematology Am Soc Hematol Educ Program; 2020 Dec; 2020(1):160-166. PubMed ID: 33275743
[TBL] [Abstract][Full Text] [Related]
8. Beta Thalassemia: Monitoring and New Treatment Approaches.
Khandros E; Kwiatkowski JL
Hematol Oncol Clin North Am; 2019 Jun; 33(3):339-353. PubMed ID: 31030806
[TBL] [Abstract][Full Text] [Related]
9. Current approach to iron chelation in children.
Aydinok Y; Kattamis A; Viprakasit V
Br J Haematol; 2014 Jun; 165(6):745-55. PubMed ID: 24646011
[TBL] [Abstract][Full Text] [Related]
10. New therapeutic targets in transfusion-dependent and -independent thalassemia.
Cappellini MD; Motta I
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):278-283. PubMed ID: 29222267
[TBL] [Abstract][Full Text] [Related]
11. Iron overload and iron-chelating therapy in hemoglobin E-beta thalassemia.
Olivieri NF; De Silva S; Premawardena A; Sharma S; Viens AM; Taylor CM; Brittenham GM; Weatherall DJ
J Pediatr Hematol Oncol; 2000; 22(6):593-7. PubMed ID: 11132236
[TBL] [Abstract][Full Text] [Related]
12. A randomized double-blind, placebo-controlled study of therapeutic effects of silymarin in β-thalassemia major patients receiving desferrioxamine.
Moayedi B; Gharagozloo M; Esmaeil N; Maracy MR; Hoorfar H; Jalaeikar M
Eur J Haematol; 2013 Mar; 90(3):202-9. PubMed ID: 23278124
[TBL] [Abstract][Full Text] [Related]
13. Iron chelation therapy in the management of thalassemia: the Asian perspectives.
Viprakasit V; Lee-Lee C; Chong QT; Lin KH; Khuhapinant A
Int J Hematol; 2009 Nov; 90(4):435-445. PubMed ID: 19862602
[TBL] [Abstract][Full Text] [Related]
14. Red blood cell transfusion therapy and iron chelation in patients with myelodysplastic syndromes.
Malcovati L
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S305-11. PubMed ID: 19778858
[TBL] [Abstract][Full Text] [Related]
15. Iron overload in β-thalassemia intermedia: an emerging concern.
Musallam KM; Cappellini MD; Taher AT
Curr Opin Hematol; 2013 May; 20(3):187-92. PubMed ID: 23426199
[TBL] [Abstract][Full Text] [Related]
16. Treatment of iron overload in thalassemia.
Cianciulli P
Pediatr Endocrinol Rev; 2008 Oct; 6 Suppl 1():208-13. PubMed ID: 19337180
[TBL] [Abstract][Full Text] [Related]
17. Daily alternating deferasirox and deferiprone therapy for "hard-to-chelate" beta-thalassemia major patients.
Balocco M; Carrara P; Pinto V; Forni GL
Am J Hematol; 2010 Jun; 85(6):460-1. PubMed ID: 20513129
[No Abstract] [Full Text] [Related]
18. Is there a standard-of-care for transfusion therapy in thalassemia?
Franchini M; Forni GL; Liumbruno GM
Curr Opin Hematol; 2017 Nov; 24(6):558-564. PubMed ID: 28719386
[TBL] [Abstract][Full Text] [Related]
19. Thalassemia Major: Transplantation or Transfusion and Chelation.
Mohamed SY
Hematol Oncol Stem Cell Ther; 2017 Dec; 10(4):290-298. PubMed ID: 28651066
[TBL] [Abstract][Full Text] [Related]
20. Australian guidelines for the assessment of iron overload and iron chelation in transfusion-dependent thalassaemia major, sickle cell disease and other congenital anaemias.
Ho PJ; Tay L; Lindeman R; Catley L; Bowden DK
Intern Med J; 2011 Jul; 41(7):516-24. PubMed ID: 21615659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
